Treatment Side Effects Epilepsy: Quality of Life in Children

What was studied

Researchers examined health-related quality of life and treatment-related adverse effects in 101 children with epilepsy enrolled in a prospective cohort in Lebanon. This was a cross-sectional analysis, meaning the measures were assessed at one point in time.

Quality of life was measured with the Arabic QOLCE-55, and adverse effects were measured with the Liverpool Adverse Events Profile. The researchers used adjusted statistical models to examine how treatment adverse effects and clinical characteristics were associated with overall quality of life and its physical, social, and emotional domains.

What they found

The median overall QOLCE-55 score was 66, with an interquartile range of 55.68 to 79.41. The physical domain had the lowest median score at 44.44 (IQR 30.55 to 59.72), while the social domain had the highest at 82.14 (IQR 67.85 to 96.42).

Greater adverse-effect burden had the strongest independent association with poorer overall quality of life. Each one-unit increase in the adverse-effect score was associated with a 0.97-point lower quality-of-life score in the adjusted model (B = -0.97, 95% CI -1.28 to -0.67; p < 0.001). Adding adverse effects to the models increased the explained variation by as much as 0.310, and adverse-effect burden was associated with poorer scores across all quality-of-life domains.

Most seizure-related variables were not statistically significant after adjustment. Longer epilepsy duration remained associated with poorer physical quality of life, while focal epilepsy was associated with lower social and emotional scores.

Limits of the evidence

Because this was a cross-sectional analysis, it cannot show that treatment adverse effects caused poorer quality of life or establish which came first. The study included 101 children from a cohort in Lebanon, so the findings may not apply to all children, healthcare systems, or cultural settings.

The abstract does not report participants' exact ages, medication types or numbers, seizure-frequency distribution, recruitment details, questionnaire respondent, or every factor included in the adjusted models. It also does not state what size difference in scores families would consider meaningful.

For families and caregivers

In this group, treatment-related adverse effects were more strongly associated with quality of life than most measured seizure-related variables. This suggests that routinely asking about treatment tolerability may be an important part of patient-centered epilepsy care. The findings do not mean seizure control is unimportant, and they do not show that changing treatment will necessarily improve quality of life.

What to watch next

Larger studies that follow children over time and test whether safely reducing adverse-effect burden improves quality of life would strengthen the evidence.

Terms in this summary

Health-related quality of life (HRQOL)

A measure of how health and treatment relate to physical, emotional, and social well-being.

QOLCE-55

A questionnaire used to assess quality of life in children with epilepsy.

Liverpool Adverse Events Profile (LAEP)

A questionnaire used to measure treatment-related adverse-effect burden.

Cross-sectional analysis

A study that examines information at one point in time and therefore cannot establish cause and effect.

Interquartile range (IQR)

The range containing the middle half of participants' scores.

Regression coefficient (B)

A statistical estimate of how much an outcome changes when another measure increases by one unit, after accounting for factors included in the model.

95% confidence interval

A range of values that reflects uncertainty around a statistical estimate.

Focal epilepsy

Epilepsy in which seizures begin in a particular area or network of the brain.